THOUSAND OAKS, Calif.,
Oct. 2, 2015 /PRNewswire/ -- Amgen
(NASDAQ:AMGN) will present at the Barclays Biosimilars Symposium at
8 a.m. ET on Wednesday, Oct. 7, 2015, in New York City. Scott
Foraker, vice president and general manager of Biosimilars
at Amgen, will present at the conference. Live audio of the
presentation can be accessed from the Events Calendar on Amgen's
website, www.amgen.com, under Investors. A replay of the webcast
will also be available on Amgen's website for at least 90 days
following the event.
About Amgen
Amgen is committed to unlocking the
potential of biology for patients suffering from serious illnesses
by discovering, developing, manufacturing and delivering innovative
human therapeutics. This approach begins by using tools like
advanced human genetics to unravel the complexities of disease and
understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages
its biologics manufacturing expertise to strive for solutions that
improve health outcomes and dramatically improve people's lives. A
biotechnology pioneer since 1980, Amgen has grown to be one of the
world's leading independent biotechnology companies, has reached
millions of patients around the world and is developing a pipeline
of medicines with breakaway potential.
For more information, visit www.amgen.com and follow us on
www.twitter.com/amgen.
CONTACT: Amgen, Thousand
Oaks
Kristen Davis, 805-447-3008
(media)
Kristen Neese, 805-313-8267
(media)
Arvind Sood, 805-447-1060
(investors)
Logo -
http://photos.prnewswire.com/prnh/20081015/AMGENLOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-barclays-biosimilars-symposium-300153555.html
SOURCE Amgen